Cargando…
In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds
Cisplatin is one of the most commonly used drugs for the treatment of various solid cancers. However, its efficacy is restricted by severe side effects, especially dose-limiting nephrotoxicity. New platinum-based compounds are designed to overcome this limitation. Previous investigations showed that...
Autores principales: | Schoch, Sarah, Sen, Vasily, Brenner, Walburgis, Hartwig, Andrea, Köberle, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394219/ https://www.ncbi.nlm.nih.gov/pubmed/34440237 http://dx.doi.org/10.3390/biomedicines9081033 |
Ejemplares similares
-
Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
por: Schoch, Sarah, et al.
Publicado: (2020) -
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
por: Köberle, Beate, et al.
Publicado: (2021) -
Acute and chronic nephrotoxicity of platinum nanoparticles in mice
por: Yamagishi, Yoshiaki, et al.
Publicado: (2013) -
Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity
por: Abdelsalam, Mostafa, et al.
Publicado: (2018) -
Establishment and Validation of an In Vitro Screening Method for Traditional Chinese Medicine-Induced Nephrotoxicity
por: Ma, Zhe, et al.
Publicado: (2018)